Pluri Inc
NASDAQ:PLUR

Watchlist Manager
Pluri Inc Logo
Pluri Inc
NASDAQ:PLUR
Watchlist
Price: 4.24 USD -4.72% Market Closed
Market Cap: 23.6m USD
Have any thoughts about
Pluri Inc?
Write Note

EV/EBIT
Enterprise Value to EBIT

-1
Current
-0.5
Median
4.3
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-1
=
Enterprise Value
23.1m USD
/
EBIT
-22m USD
All Countries
Close
Market Cap EV/EBIT
IL
Pluri Inc
NASDAQ:PLUR
23.4m USD -1
FR
Pharnext SCA
OTC:PNEXF
6T USD -220 933.3
US
Abbvie Inc
NYSE:ABBV
309.5B USD 23.4
US
Amgen Inc
NASDAQ:AMGN
140.9B USD 30.3
US
Gilead Sciences Inc
NASDAQ:GILD
112B USD 9.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.6B USD 22.8
US
Epizyme Inc
F:EPE
94.1B EUR -492.1
AU
CSL Ltd
ASX:CSL
137.8B AUD 24.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
76.7B USD 16.6
US
Seagen Inc
F:SGT
39.3B EUR -52.1
NL
argenx SE
XBRU:ARGX
38.5B EUR -108.3
EBIT Growth EV/EBIT to Growth
IL
Pluri Inc
NASDAQ:PLUR
Average EV/EBIT: 21.3
Negative Multiple: -1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -220 933.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
24%
1
US
Amgen Inc
NASDAQ:AMGN
30.3
24%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
10%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.8
13%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -492.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.7
16%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
12%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -52.1 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -108.3 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A